Department of Pathology, College of Basic Medical Sciences, First Affiliated Hospital of China Medical University, North 2nd Road 92, Heping Ward, Shenyang, 110001, People's Republic of China.
Radiat Oncol. 2012 Oct 31;7:183. doi: 10.1186/1748-717X-7-183.
Histone deacetylase (HDAC) plays an important role in the deacetylation of histone, which can alter gene expression patterns and affect cell behavior associated with malignant transformation. The aims of this study were to investigate the relationships between HDAC1, HDAC2, clinicopathologic characteristics, patient prognosis and apoptosis, to clarify the mechanism of upregulation of the Axis inhibitor Axin (an important regulator of the Wnt pathway) by X-radiation and to elucidate the effect of siRNA on radiation therapy of non-small cell lung cancer (NSCLC).
HDAC1 and HDAC2 expression levels were measured by immunohistochemistry and reverse transcription PCR. Apoptosis was determined by terminal deoxynucleotidyl transferase-mediated dUTP-nick end labeling and fluorescence activated cell sorting. BE1 cells expressing Axin were exposed to 2 Gy of X-radiation.
Expression of HDAC1 and that of HDAC2 were correlated, and significantly higher in NSCLC tissues than in normal lung tissues (P < 0.05). HDAC1 and HDAC2 expression was correlated with pTNM stage and negatively correlated with differentiation of NSCLC and apoptotic index (P < 0.05). The prognosis of patients with low expression of HDAC1 and HDAC2 was better than that of those with high expression. X-radiation and siRNA inhibited HDAC1 and HDAC2 expression in NSCLC cells and Axin levels were significantly higher in BE1 cells.
X-radiation and siRNA inhibit expression of HDAC1 and HDAC2, weaken the inhibitory effect of HDAC on Axin, upregulate Axin expression and induce apoptosis of lung cancer cells. Inhibition of HDAC1 and HDAC2 is a means of enhancing the radiosensitivity of NSCLC.
组蛋白去乙酰化酶(HDAC)在组蛋白去乙酰化中起重要作用,可改变基因表达模式,并影响与恶性转化相关的细胞行为。本研究旨在探讨 HDAC1、HDAC2 与临床病理特征、患者预后和细胞凋亡的关系,阐明 X 射线上调轴抑制因子 Axin(Wnt 通路的重要调节因子)的机制,并阐明 siRNA 对非小细胞肺癌(NSCLC)放射治疗的影响。
采用免疫组化和逆转录 PCR 检测 HDAC1 和 HDAC2 的表达水平。通过末端脱氧核苷酸转移酶介导的 dUTP-切口末端标记和荧光激活细胞分选检测细胞凋亡。用 2 Gy X 射线照射表达 Axin 的 BE1 细胞。
HDAC1 和 HDAC2 的表达呈正相关,且 NSCLC 组织中的表达明显高于正常肺组织(P<0.05)。HDAC1 和 HDAC2 的表达与 pTNM 分期相关,与 NSCLC 的分化和凋亡指数呈负相关(P<0.05)。HDAC1 和 HDAC2 低表达的患者预后优于高表达的患者。X 射线和 siRNA 抑制 NSCLC 细胞中 HDAC1 和 HDAC2 的表达,且 BE1 细胞中 Axin 水平明显升高。
X 射线和 siRNA 抑制 HDAC1 和 HDAC2 的表达,减弱 HDAC 对 Axin 的抑制作用,上调 Axin 的表达并诱导肺癌细胞凋亡。抑制 HDAC1 和 HDAC2 是增强 NSCLC 放射敏感性的一种手段。